PROLASTIN-C
Google image searchProduct monograph
Active ingredient
alpha1-proteinase inhibitor (human), 1000 MG/VIAL
DIN: 02204606
Dosage form(s): POWDER FOR SOLUTION
Route(s) of administration: INTRAVENOUS
Schedule: Schedule D
Company: GRIFOLS THERAPEUTICS LLC
Date: 04-FEB-2012
ATC:
- B02 — ANTIHEMORRHAGICS (ATC, ATC/DDD, )
- B02A — ANTIFIBRINOLYTICS (ATC, ATC/DDD)
- B02AB — Proteinase inhibitors (ATC, ATC/DDD)
- B02AB02 — ALFA1 ANTITRYPSIN (ATC/DDD)
Reference brand drug: Prolastin, Glassia
Pharmaceutical standard: MFR
